Trial
NCT02263677
Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Missouri-Columbia
Collaborators
—
Condition
Type 2 Diabetes
Intervention
Sitagliptin
Why stopped
Technical difficulties have caused this study to be terminated
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-10-05